logo
  

GlaxoSmithKline : FDA Approves Shingrix To Prevent Shingles In Immunocompromised Adults

The US Food and Drug Administration has approved Shingrix--Zoster Vaccine Recombinant, Adjuvanted-- for the prevention of shingles in adults aged 18 years and older who are or who will be at increased risk of shingles due to immunodeficiency or immunosuppression caused by known disease or therapy, GlaxoSmithKline Plc. (GSK.L,GSK) said in a statement.

Immunocompromised individuals are at greater risk of shingles and associated complications than immunocompetent individuals.

Shingrix, a non-live, recombinant sub-unit adjuvanted vaccine, given intramuscularly in two doses, was initially approved by FDA in 2017 for the prevention of shingles in adults 50 years of age or older. Shingrix is not indicated for prevention of primary varicella infection or chickenpox.

The US Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices has begun discussions to consider recommendations for use of Shingrix in immunocompromised adults, GlaxoSmithKline said.

Shingrix was previously approved by the European Commission for prevention of shingles and post-herpetic neuralgia (PHN) in adults 18 years of age or older at increased risk of shingles and granted marketing authorization on August 25, 2020.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple announced that Apple News will be extending its local news offering to three additional cities in the United States to offer local news experience to readers. The service will now be provided for Charlotte, Miami, and Washington, D.C. The local news experience for each city is curated by Apple News editors to provide coverage of topics of importance for local communities. Automaker General Motors Co. (GM) on Wednesday reported third-quarter net income attributable to shareholders of $2.42 billion or $1.62 per share, lower than $4.05 billion or $2.78 per share in the prior-year quarter. Excluding items, adjusted net income for the quarter was $1.52 per share, compared... Boeing on Wednesday reported a loss for the first quarter that sharply narrowed from last year, reflecting an 8 percent increase in revenues on higher commercial airplanes and services volumes. However, core loss per share and quarterly revenues came in below analysts' expectations. Looking ahead, the airplane maker said supply chain capacity and global trade will be key drivers of the industry.
Follow RTT